Show simple item record

dc.contributor.authorSánchez Morillo, Daniel 
dc.contributor.authorLeón Jiménez, Antonio
dc.contributor.authorGuerrero Chanivet, María 
dc.contributor.authorJiménez-Gómez, Gema
dc.contributor.authorHidalgo Molina, Antonio
dc.contributor.authorCampos Caro, Antonio 
dc.contributor.otherIngeniería en Automática, Electrónica, Arquitectura y Redes de Computadoreses_ES
dc.date.accessioned2024-07-01T11:37:11Z
dc.date.available2024-07-01T11:37:11Z
dc.date.issued2024-06-28
dc.identifier.issn2380-6761
dc.identifier.urihttp://hdl.handle.net/10498/32829
dc.description.abstractEngineered stone silicosis (ESS), primarily caused by inhaling respirable crystalline silica, poses a significant occupational health risk globally. ESS has no effective treatment and presents a rapid progression from simple silicosis (SS) to progressive massive fibrosis (PMF), with respiratory failure and death. Despite the use of diagnostic methods like chest x-rays and high-resolution computed tomography, early detection of silicosis remains challenging. Since routine blood tests have shown promise in detecting inflammatory markers associated with the disease, this study aims to assess whether routine blood biomarkers, coupled with machine learning techniques, can effectively differentiate between healthy individuals, subjects with SS, and PMF. To this end, 107 men diagnosed with silicosis, ex-workers in the engineered stone (ES) sector, and 22 healthy male volunteers as controls not exposed to ES dust were recruited. Twenty-one primary biochemical markers derived from peripheral blood extraction were obtained retrospectively from clinical hospital records. Relief-F features selection technique was applied, and the resulting subset of 11 biomarkers was used to build five machine learning models, demonstrating high performance with sensitivities and specificities in the best case greater than 82% and 89%, respectively. The percentage of lymphocytes, the angiotensin-converting enzyme, and lactate dehydrogenase indexes were revealed, among others, as blood biomarkers with significant cumulative importance for the machine learning models. Our study reveals that these biomarkers could detect a chronic inflammatory status and potentially serve as a supportive tool for the diagnosis, monitoring, and early detection of the progression of silicosis.es_ES
dc.description.sponsorshipThis work was funded in the “Convocatoria 2021 de Ayudas a Proyectos de Excelencia, en régimen de concurrencia competitiva, destinadas a entidades calificadas como Agentes del Sistema Andaluz del Conocimiento, en el ámbito del Plan Andaluz de Investigación, Desarrollo e Innovación (PAIDI 2020). Consejería de Universidad, Investigación e Innovación de la Junta de Andalucía,” under grant number ProyExcel_00942 and by the Programa Estatal de Generación de Conocimiento y Fortalecimiento del Sistema Español de I + D + i, funded by the Instituto de Salud Carlos III and Fondo Europeo de Desarrollo Regional (FEDER) 2014–2020 (grant number PI19/01064) and 2021-2027 (grant number PI23/01475).es_ES
dc.formatapplication/pdfes_ES
dc.language.isoenges_ES
dc.publisherWiley Periodicals LLCes_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.sourceBioeng Transl Med. 2024;e10694es_ES
dc.subjectartificial stonees_ES
dc.subjectblood biomarkerses_ES
dc.subjectengineered stonees_ES
dc.subjectmachine learninges_ES
dc.subjectsilica agglomeratees_ES
dc.subjectsilicosises_ES
dc.titleIntegrating routine blood biomarkers and artificial intelligencefor supporting diagnosis of silicosis in engineered stone workerses_ES
dc.typejournal articlees_ES
dc.identifier.urlhttps://aiche.onlinelibrary.wiley.com/doi/full/10.1002/btm2.10694
dc.rights.accessRightsopen accesses_ES
dc.identifier.doidoi:10.1002/btm2.10694
dc.relation.projectIDinfo:eu-repo/grantAgreement/ISCIII/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 (ISCIII)/PI19%2F01064/ES/SILICOSIS POR AGLOMERADOS DE CUARZO ARTIFICIAL: BUSQUEDA DE BIOMARCADORES DIAGNOSTICOS %2F PREDICTIVOS DE LA ENFERMEDAD, USO DE PET %2F TC COMO TECNICA DE SEGUIMIENTO DE LA ENFERMEDAD Y ENSAYO CLINICO CON PIRFENIDONA./ es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ISCIII/Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2027 (ISCIII)/PI23%2F01475 es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/Junta de Andalucia//ProyExcel_00942es_ES
dc.type.hasVersionVoRes_ES


Files in this item

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
This work is under a Creative Commons License Attribution-NonCommercial-NoDerivatives 4.0 Internacional